USD 17.16
(-0.46%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 1.65 Billion AUD | -3.59% |
2023 | 1.72 Billion AUD | -45.89% |
2022 | 2.8 Billion AUD | -3.95% |
2021 | 2.15 Billion AUD | 155.65% |
2020 | 1.04 Billion AUD | 18.03% |
2019 | 971.26 Million AUD | 7.94% |
2018 | 899.82 Million AUD | 8.67% |
2017 | 828.05 Million AUD | 2.28% |
2016 | 809.56 Million AUD | 21.47% |
2015 | 666.46 Million AUD | -6.09% |
2014 | 709.66 Million AUD | 9.28% |
2013 | 649.27 Million AUD | 3.58% |
2012 | 626.69 Million AUD | 8.77% |
2011 | 575.91 Million AUD | 3.33% |
2010 | 556.9 Million AUD | -3.89% |
2009 | 580.41 Million AUD | 19.07% |
2008 | 487.47 Million AUD | 19.04% |
2007 | 409.49 Million AUD | 12.87% |
2006 | 359.38 Million AUD | 17.78% |
2005 | 308.03 Million AUD | 31.3% |
2004 | 234.61 Million AUD | 11.77% |
2003 | 209.9 Million AUD | 13.21% |
2002 | 185.41 Million AUD | 127.1% |
2001 | 138.2 Million AUD | 45.63% |
2000 | 56.06 Million AUD | 77.74% |
1999 | 31.54 Million AUD | 46.27% |
1998 | 21.56 Million AUD | 49.56% |
1997 | 14.41 Million AUD | 23.45% |
1996 | 11.68 Million AUD | 63.22% |
1995 | 7.15 Million AUD | 71.61% |
1994 | 4.17 Million AUD | 175.07% |
1993 | 1.51 Million AUD | 19.46% |
1992 | 1.26 Million AUD | 117.12% |
1991 | -7.41 Million AUD | -6894.34% |
1990 | -106 Thousand AUD | 78.63% |
1989 | -496 Thousand AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - AUD | -11.21% |
2024 Q2 | 717.17 Million AUD | 0.0% |
2024 Q4 | 602.98 Million AUD | 0.0% |
2023 Q4 | 648.18 Million AUD | 0.0% |
2023 FY | - AUD | -45.89% |
2023 Q2 | 880.07 Million AUD | 0.0% |
2022 FY | - AUD | -3.95% |
2022 Q2 | 1.57 Billion AUD | 0.0% |
2022 Q4 | 1.23 Billion AUD | 0.0% |
2021 Q2 | 1.36 Billion AUD | 0.0% |
2021 Q4 | 1.57 Billion AUD | 0.0% |
2021 FY | - AUD | 155.65% |
2020 FY | - AUD | 18.03% |
2020 Q2 | 607.29 Million AUD | 0.0% |
2020 Q4 | 580.64 Million AUD | 0.0% |
2019 Q4 | 499.1 Million AUD | 0.0% |
2019 Q2 | 472.92 Million AUD | 0.0% |
2019 FY | - AUD | 7.94% |
2018 FY | - AUD | 8.67% |
2018 Q4 | 453.25 Million AUD | 0.0% |
2018 Q2 | 446.57 Million AUD | 0.0% |
2017 Q2 | 409.16 Million AUD | 0.0% |
2017 Q4 | 418.88 Million AUD | 0.0% |
2017 FY | - AUD | 2.28% |
2016 FY | - AUD | 21.47% |
2016 Q4 | 407.93 Million AUD | 0.0% |
2016 Q2 | 401.62 Million AUD | 0.0% |
2015 Q2 | 347.71 Million AUD | 0.0% |
2015 FY | - AUD | -6.09% |
2015 Q4 | 318.75 Million AUD | 0.0% |
2014 Q2 | 346.41 Million AUD | 0.0% |
2014 FY | - AUD | 9.28% |
2014 Q4 | 363.25 Million AUD | 0.0% |
2013 Q3 | 161.1 Million AUD | 4.95% |
2013 Q1 | 153.5 Million AUD | 0.0% |
2013 Q2 | 153.5 Million AUD | 0.0% |
2013 Q4 | 322.21 Million AUD | 100.0% |
2013 FY | - AUD | 3.58% |
2012 FY | - AUD | 8.77% |
2012 Q4 | - AUD | 0.0% |
2011 Q4 | - AUD | 0.0% |
2011 FY | - AUD | 3.33% |
2010 FY | - AUD | -3.89% |
2010 Q4 | - AUD | 0.0% |
2009 FY | - AUD | 19.07% |
2009 Q4 | - AUD | 0.0% |
2008 Q4 | - AUD | 0.0% |
2008 FY | - AUD | 19.04% |
2007 FY | - AUD | 12.87% |
2007 Q4 | - AUD | 0.0% |
2006 FY | - AUD | 17.78% |
2006 Q4 | - AUD | 0.0% |
2005 FY | - AUD | 31.3% |
2005 Q4 | - AUD | 0.0% |
2004 FY | - AUD | 11.77% |
2004 Q4 | - AUD | 0.0% |
2003 Q4 | - AUD | 0.0% |
2003 FY | - AUD | 13.21% |
2002 FY | - AUD | 127.1% |
2002 Q4 | - AUD | 0.0% |
2001 FY | - AUD | 45.63% |
2001 Q4 | - AUD | 0.0% |
2000 Q4 | - AUD | 0.0% |
2000 FY | - AUD | 77.74% |
1999 Q4 | - AUD | 0.0% |
1999 FY | - AUD | 46.27% |
1998 FY | - AUD | 49.56% |
1998 Q4 | - AUD | 0.0% |
1997 FY | - AUD | 23.45% |
1997 Q4 | - AUD | 0.0% |
1996 FY | - AUD | 63.22% |
1995 FY | - AUD | 71.61% |
1994 FY | - AUD | 175.07% |
1993 FY | - AUD | 19.46% |
1992 FY | - AUD | 117.12% |
1991 FY | - AUD | -6894.34% |
1990 FY | - AUD | 78.63% |
1989 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Bio Medica Corporation | -1.16 Million USD | 142774.377% |
Arrayit Corporation | -3.07 Million USD | 54017.326% |
Atlantic International Corp. | -5.38 Million USD | 30887.356% |
Biocept, Inc. | -30.24 Million USD | 5586.932% |
Bioqual, Inc. | 3.03 Million USD | -54622.021% |
CardioGenics Holdings Inc | -757.37 Thousand USD | 219186.054% |
DermTech, Inc. | -97.89 Million USD | 1795.017% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 43.06% |
HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 8297.142% |
iMD Companies, Inc. | -154.65 Thousand USD | 1072978.397% |
IDenta Corp. | 71.58 Thousand USD | -2317783.135% |
Interpace Biosciences, Inc. | 3.83 Million USD | -43144.801% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | -4288612.846% |
InVitro International | 6680.00 USD | -24839765.269% |
Lumos Diagnostics Holdings Limited | -5.43 Million USD | 30624.338% |
Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 13674922.812% |
Medical Imaging Corp. | -896.74 Thousand USD | 185136.833% |
NovelStem International Corp. | -3.78 Million USD | 43929.664% |
Optigenex Inc. | -1.18 Million USD | 139922.149% |
PharmChem, Inc. | 1.05 Million USD | -157357.511% |
Proteome Sciences plc | -1.13 Million USD | 146036.939% |
Response Genetics, Inc | -19.66 Million USD | 8537.42% |
Rennova Health, Inc. | -234.81 Thousand USD | 706742.676% |
RushNet, Inc. | -614.85 Thousand USD | 269970.31% |
ScreenPro Security Inc. | -3.43 Million USD | 48407.325% |
Stella Diagnostics Inc. | -5.7 Million USD | 29172.682% |
StageZero Life Sciences Ltd. | -10.27 Million USD | 16256.576% |
Todos Medical Ltd. | -9.39 Million USD | 17763.434% |